Wall Street is positive on ADC Therapeutics SA (ADCT). On average, analysts give ADC Therapeutics SA a Strong Buy rating. The average price target is $48.75, which means analysts expect the stock to increase by 65.25% over the next twelve months.
That average ranking earns ADC Therapeutics SA an Analyst Rating of 60, which is better than 60% of stocks based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With ADC Therapeutics SA Stock Today?
ADC Therapeutics SA (ADCT) stock is trading at $29.50 as of 2:14 PM on Tuesday, Feb 23, a drop of -$1.09, or -3.56% from the previous closing price of $30.59. The stock has traded between $28.46 and $30.51 so far today. Volume today is 243,384 compared to average volume of 235,861.
Click Here to get the full report on ADC Therapeutics SA (ADCT) Stock.
